{{overview_title}}
{{overview_content}}
{{mechanism_title}}
{{mechanism_content}}
{{benefits_title}}
{{research_title}}
{{research_content}}
{{safety_title}}
{{safety_content}}
Recommended products
Research peptides selected for quality and purity:
Top Pick
GHK-Cu
Anti-Aging Compound
Test your knowledge
Quick quiz · 6 questions
Frequently Asked Questions
Is sermorelin the same as HGH?
No. HGH (human growth hormone) is the finished hormone, supplied directly when injected. Sermorelin is a GHRH analog that stimulates your own pituitary gland to produce and release growth hormone. The key difference is that sermorelin preserves the body's natural feedback regulation and pulsatile secretion pattern, whereas synthetic HGH bypasses those controls. Sermorelin also requires a functioning pituitary to work.
Is sermorelin FDA approved?
Sermorelin was previously FDA approved under the brand name Geref for diagnostic testing of pituitary function and for treating growth hormone deficiency in children. That product was discontinued in the United States in 2008 for commercial reasons, not safety. There is currently no FDA-approved commercial sermorelin product; it is most often obtained as a compounded prescription or sold as a research-use-only peptide. It is not approved for anti-aging use.
How long does it take for sermorelin to work?
Because sermorelin works by stimulating your body's own growth hormone production rather than supplying it directly, perceptible changes tend to develop gradually. While GH is released within minutes of a dose, downstream effects on sleep quality, recovery and body composition — where they occur — typically emerge over weeks to months. Objective monitoring of IGF-1 by a clinician is more reliable than short-term subjective impressions.
What are the most common sermorelin side effects?
The most frequently reported side effects are mild injection-site reactions such as redness, swelling or itching. Others include flushing, headache, dizziness, a feeling of warmth, and occasionally nausea or altered taste. Because sermorelin raises GH and IGF-1, excessive dosing could in principle contribute to fluid retention, joint aching or effects on blood sugar. People with a cancer history, diabetes, or who are pregnant should avoid it or use it only under specialist supervision.
Can sermorelin be combined with other peptides?
In clinical and research settings, sermorelin is sometimes combined with a growth hormone secretagogue such as ipamorelin, because the two act on different receptors and can amplify GH release together. It is also compared with longer-acting GHRH analogs like CJC-1295. However, combining secretagogues increases both potential effects and uncertainties, human evidence for specific stacks in healthy adults is limited, and any combination should only be used under qualified medical supervision.
Sources
- Walker RF (2006). Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?. Clinical Interventions in Aging.
- Prakash A, Goa KL (1999). Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs.
- Baker LD, Barsness SM, Borson S, et al. (2012). Effects of growth hormone-releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults. Archives of Neurology.
- Vittone J, Blackman MR, Busby-Whitehead J, et al. (1997). Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism.
- Khorram O, Laughlin GA, Yen SS (1997). Endocrine and metabolic effects of long-term administration of growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. The Journal of Clinical Endocrinology & Metabolism.
- Corpas E, Harman SM, Piñeyro MA, et al. (1992). Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and IGF-I levels in old men. The Journal of Clinical Endocrinology & Metabolism.